VRNA

Verona Pharma

151 hedge funds and large institutions have $1.95B invested in Verona Pharma in 2024 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 42 increasing their positions, 48 reducing their positions, and 19 closing their positions.

Holders
151
Holders Change
+26
Holders Change %
+20.8%
% of All Funds
2.18%
Holding in Top 10
11
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+57.14%
% of All Funds
0.16%
New
45
Increased
42
Reduced
48
Closed
19
Calls
$24.3M
Puts
$27.6M
Net Calls
-$3.24M
Net Calls Change
-$3.55M
Name Market Value Shares Shares
Change
Shares
Change %
HCP
151
Hexagon Capital Partners
Arkansas
$86 3 +3 New
O
152
OrbiMed
New York
-2,861,801 Closed
CG
153
Carlyle Group
District of Columbia
-2,457,500 Closed
LCM
154
Laurion Capital Management
New York
-1,050,842 Closed
PBA
155
Paradigm Biocapital Advisors
New York
-721,087 Closed
IC
156
Ikarian Capital
Texas
-201,116 Closed
Adage Capital Partners
157
Adage Capital Partners
Massachusetts
-175,000 Closed
JF
158
Jump Financial
Illinois
-168,438 Closed
Susquehanna International Group
159
Susquehanna International Group
Pennsylvania
-117,397 Closed
CM
160
CM Management
Florida
-35,000 Closed
State Street
161
State Street
Massachusetts
-33,572 Closed
Renaissance Technologies
162
Renaissance Technologies
New York
-31,044 Closed
Ameriprise
163
Ameriprise
Minnesota
-13,159 Closed
Nomura Holdings
164
Nomura Holdings
Japan
-10,000 Closed
NA
165
NewEdge Advisors
Louisiana
-7,300 Closed
QL
166
Quarry LP
New York
-2,000 Closed
RWMG
167
Redwood Wealth Management Group
New Jersey
-410 Closed
National Bank of Canada
168
National Bank of Canada
Quebec, Canada
-150 Closed
NMM
169
Naples Money Management
Florida
-100 Closed
Northwestern Mutual Wealth Management
170
Northwestern Mutual Wealth Management
Wisconsin
-64 Closed
CFGS
171
Concourse Financial Group Securities
Alabama
D.E. Shaw & Co
172
D.E. Shaw & Co
New York
Wolverine Trading
173
Wolverine Trading
Illinois